Berry Genomics Co.,Ltd (SHE:000710)
12.36
-0.13 (-1.04%)
Feb 26, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Market Cap
Berry Genomics Co.,Ltd has a market cap or net worth of 4.42 billion as of February 26, 2026. Its market cap has increased by 46.08% in one year.
Market Cap
4.42B
Enterprise Value
4.42B
Revenue
941.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.36
Market Cap Chart
Since June 20, 2017, Berry Genomics Co.,Ltd's market cap has decreased from 24.43B to 4.42B, a decrease of -81.92%. That is a compound annual growth rate of -17.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 4.42B | 10.63% |
| Dec 31, 2025 | 3.99B | 33.61% |
| Dec 31, 2024 | 2.99B | -26.65% |
| Dec 29, 2023 | 4.07B | 0.96% |
| Dec 30, 2022 | 4.03B | -40.71% |
| Dec 31, 2021 | 6.80B | -49.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.07B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 7.15B |
| Cowealth Medical China | 6.68B |
| SMO ClinPlus CO.,LTD. | 5.28B |
| Thalys Medical Technology Group | 4.53B |
| Shanghai Labway Clinical Laboratory | 4.48B |
| Guangdong Hybribio Biotech | 4.29B |